Overview

Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this observational study is to document the course of disease and relapse management during treatment with Daivobet® Gel under consideration of patient's individual application habits under daily use conditions.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
LEO Pharma
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Calcipotriene
Criteria
Inclusion Criteria:

- Patients with light to moderate psoriasis vulgaris of trunk and extremities and
treatment with Daivobet® Gel was planned anyway.

- Minimum of 3 years diagnosed psoriasis vulgaris.

Exclusion Criteria:

- Previous therapy with Daivobet® Gel

- Systemic therapy of psoriasis vulgaris

- Contraindications of Daivobet® Gel in the German package insert

- people that are incapable to give free consent